determined that RNA-edited AZIN1 plays a significant role in the tumor vascular microenvironment and identifies IL-8 signaling, primarily through the application of small-molecule antagonists, such as reparixin, as a promising therapeutic target in hyper-edited cancer (91). The gene discussed is AZIN1; the disease is neoplasm.